There was significant heterogeneity ( p < @ ) in the efficacy of an early invasive strategy compared to standard therapy , between the strata with GPIIb/IIIa inhibitor use ( primary end point @ % vs @ % respectively , p < @ ) and without GPIIb/IIIa inhibitor use ( primary end point @ % vs @ % respectively , p = @ ) .